Recent proof-backed thesis calls
Public preview of asset-level thesis calls linked to source content, observed prices, and outcomes.
Anecdotal social post claims higher-dose Vitamin K2 (MK-4) plus Vitamin E (mixed tocopherols) improved testosterone/LH dynamics, with commentary that high LH can indicate reduced Leydig-cell sensitivity and oxidative stress/circadian factors. This is not investable as a catalyst by itself, but it loosely reinforces an existing supplement/ingredients demand narrative (fat-soluble vitamins, antioxidant positioning).
USGS-style overview of germanium: byproduct of zinc processing; demand shifted from early electronics to fiber optics, infrared/night vision, and polymerization catalysts; recent (as of text) consumption > primary production offset by stockpiles and recycling; includes a historical 2000 year-end price ($1,150/kg).
Interview-style discussion (no single new headline) about Russia’s fiscal strain (“money running out”), potential VAT (НДС) increases, ongoing/lasting sanctions, the EU debating use of frozen Russian assets, and recession risk. The actionable angle is macro/geopolitics: prolonged sanctions and higher Russia fiscal pressure tend to support defense spending, sustain energy/geopolitical risk premia, and weigh on Europe’s growth-sensitive/energy-intensive sectors. However, the entry itself does not
Current stance
Top authors on this asset
Investment decisions
Unlock full asset monitoring
Create an account to inspect complete asset history, trust-weighted rankings, and persisted evidence across authors, theses, and market events.